Outcomes
Primary outcome was the comparison of cumulated defined daily doses (DDD) of PPI per study patient after 6 months in the intervention and control group (T1). Secondary outcomes were the cumulated DDDs of PPI per study patient after 12 months (T2) and PPI intake status over time.